Evidence map›Paper›PMID 39202459›Full record

ArticleGenes2024

Comparative Analysis of Two NGS-Based Platforms for Product-of-Conception Karyotyping.

Yuri Murase, Yui Shichiri, Hidehito Inagaki, Tatsuya Nakano, Yoshiharu Nakaoka, Yoshiharu Morimoto, Tomoko Ichikawa, Haruki Nishizawa, Eiji Sugihara, Hiroki Kurahashi

Abstract readComparative Study
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuri MuraseDivision of Molecular Genetics, Center for Medical Science, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Yui ShichiriDivision of Molecular Genetics, Center for Medical Science, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Hidehito InagakiDivision of Molecular Genetics, Center for Medical Science, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Tatsuya NakanoIVF Namba Clinic, Osaka 557-0013, Japan.
Yoshiharu NakaokaIVF Namba Clinic, Osaka 557-0013, Japan.
Yoshiharu MorimotoHORAC Grandfront Osaka Clinic, Osaka 530-0011, Japan.ORCID 0000-0003-2834-2726
Tomoko IchikawaDepartment of Obstetrics and Gynecology, Nippon Medical School, Tokyo 113-0083, Japan.ORCID 0000-0001-9563-2358
Haruki NishizawaDepartment of Obstetrics and Gynecology, Fujita Health University School of Medicine, Aichi 470-1192, Japan.ORCID 0000-0002-8295-0119
Eiji SugiharaCenter for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University, Aichi 470-1192, Japan.ORCID 0000-0002-3233-1045
Hiroki KurahashiDivision of Molecular Genetics, Center for Medical Science, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.ORCID 0000-0002-5690-5218

Funding

Grant-in-Aid for Scientific Research from the Japanese Ministries of Education, Culture, Sports, Science, and Technology 23K08855Japan Agency for Medical Research and Development 23ek0109549h0003
6 · The paper itself

Abstract

Cytogenetic information about the product of conception (POC) is important to determine the presence of recurrent chromosomal abnormalities that are an indication for preimplantation genetic testing for aneuploidy or structural rearrangements. Although microscopic examination by G-staining has long been used for such an evaluation, detection failures are relatively common with this method, due to cell-culture-related issues. The utility of low-coverage whole-genome sequencing (lcWGS) using short-read next-generation sequencing (NGS) has been highlighted recently as an alternative cytogenomic approach for POC analysis. We, here, performed comparative analysis of two NGS-based protocols for this purpose based on different short-read sequencers (the Illumina VeriSeq system using a MiSeq sequencer and the Thermo Fisher ReproSeq system using an Ion S5 sequencer). The cytogenomic diagnosis obtained with each NGS method was equivalent in each of 20 POC samples analyzed. Notably, X chromosome sequence reads were reduced in some female samples with both systems. The possibility of low-level mosaicism for monosomy X as an explanation for this was excluded by FISH analysis. Additional data from samples with various degrees of X chromosome aneuploidy suggested that it was a technical artifact related to X chromosome inactivation. Indeed, subsequent nanopore sequencing indicated that the DNA in the samples showing the artifact was predominantly unmethylated. Our current findings indicate that although X chromosome data must be interpreted with caution, both the systems we tested for NGS-based lcWGS are useful alternatives for the karyotyping of POC samples.

Indexed as

AneuploidyHigh-Throughput Nucleotide SequencingKaryotypingChromosomes, Human, XFemaleHumansMalePregnancyPreimplantation DiagnosisWhole Genome SequencingkaryotypemethylationNGSproduct of conceptionX chromosome

Identifiers

PMID39202459
PMCPMC11353422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.